High-quality therapeutic antibody generation for the immuno-oncology sector
Discover the importance of high-throughput and robust methodologies for finding ‘needle-in-the-haystack’ therapeutic antibodies
Discover the importance of high-throughput and robust methodologies for finding ‘needle-in-the-haystack’ therapeutic antibodies
BLENREP is the fifth major medicine approval for GSK in 2020
The immunoassay suite from Abcam utilizes recombinant antibodies for greater consistency, sensitivity, and specificity
Integrates with Hamilton Liquid Handling Platforms and operates as a standalone device
Plans in pipeline to build a dedicated continuous bioprocessing facility in Fribourg, Switzerland, featuring Pall Life Sciences’ Cadence platform technologies
Critically ill patient suffering from multidrug-resistant Acinetobacter baumannii infection successfully treated with personalized phage therapy under Emergency IND
Scientists at the National Center for Research on Human Genomics are at the forefront of groundbreaking research to develop new drugs for major diseases